Clinical Trial Update: Study of Arginine Free IED in Critically Ill Patients. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial studying arginine-free IED in critically ill patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• Arginine Free IED (arginine-free IED)

Snippet

Sponsor: Thai Otsuka Pharmaceutical Co., Ltd. | Conditions: Critical Illness | Phase 4 | Status: COMPLETED